Roberto Wandenkolk Vieira
CIK 2150104 · President, Oncology · last filed 2026-09-03
Roberto Wandenkolk Vieira is a President, Oncology who has filed 1 SEC Form 4 insider transactions across 1 company since 2026. The most recent filing, for CORT, was dated Sep 3, 2026. Across all open-market trades the lifetime net is −$6.5M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $486.6K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$486.6K
1
1
-$6.46M
Filer Profile
REDWOOD CITY, CA 94065
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| CORT | President, Oncology | 4,206 | $115.70 | $486.6K | -$6.46M | 1 | 2026-09-03 |
Recent Filings
1 filingNotice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.